^Organon. NuvaRing now available for Australian women. 2007-03-21 [2007-04-12].[永久失效連結]
^Mencimer, Stephanie. Is NuvaRing Dangerous?. Mother Jones. 2009 [2013-06-30]. (原始内容于2013-03-19).
^New NuvaRing Blood-Clotting Lawsuit Allegations Update: Resource4thePeople Reports Lawsuits Continue to Be Filed and Trial on Track. WRCB TV. 2013 [2013-06-30]. (原始内容存档于2013-06-30).
^ 4.04.1Whitaker, Amy; Gilliam, Melissa. Contraception for Adolescent and Young Adult Women. Springer. 2014: 98 [2018-10-06]. ISBN 9781461465799. (原始内容于2016-12-29) (英语).
^The selection and use of essential medicines: Twentieth report of the WHO Expert Committee 2015 (including 19th WHO Model List of Essential Medicines and 5th WHO Model List of Essential Medicines for Children). (PDF). WHO. 2015: 334–335 [2016-12-08]. ISBN 9789240694941. (原始内容 (PDF)于2016-12-20).
^Rivera R, Yacobson I, Grimes D. The mechanism of action of hormonal contraceptives and intrauterine contraceptive devices. Am J Obstet Gynecol. 1999, 181 (5 Pt 1): 1263–9. PMID 10561657. doi:10.1016/S0002-9378(99)70120-1. The hormonal methods, particularly the low-dose progestin-only products and emergency contraceptive pills, have effects on the endometrium that, theoretically, could affect implantation. However, no scientific evidence indicates that prevention of implantation actually results from the use of these methods.
^ 9.09.19.2Phelps, Rachel. . Association of Reproductive Health Professionals. Bayer Healthcare Pharmaceuticals, Conceptus, Inc., and Teva Pharmaceuticals. 2014-06-01 [2016-09-16]. (原始内容存档于2018-01-02).
^ 10.010.1Dahiya, P. Efficacy of combined hormonal vaginal ring in comparison to combined hormonal pills in heavy menstrual bleeding. Eur J Obstet Gynecol Reprod Biol. 2016-05-20, 203: 147–51. PMID 27285306. doi:10.1016/j.ejogrb.2016.05.009 –通过PubMed.
^Trussell, J. Contraceptive failure in the United States. Contraception. 2011, 83 (5): 397–404. PMC 3638209. PMID 21477680. doi:10.1016/j.contraception.2011.01.021 –通过PubMed.